Lucid Diagnostics Inc. (LUCD) vs RxSight, Inc. (RXST)
Lucid Diagnostics Inc. and RxSight, Inc. are both Medical Devices companies. RxSight, Inc. is the larger, with a market value of $196.7M against $170.3M — 1.2× the size. Lucid Diagnostics Inc. grew revenue faster over the last twelve months: 24.9% against −13.3%. RxSight, Inc. has the higher net margin (−36.8% vs −1,193.9%) and the higher return on invested capital (−63.2% vs −3,096.5%). Across the 17 metrics below, RxSight, Inc. leads on 13 and Lucid Diagnostics Inc. on 4.
Valuation
Profitability
| Metric | LUCD | RXST | Medical Devices median |
|---|---|---|---|
| Gross margin | (21.69%) | 77.50% | 56.01% |
| Operating margin | (930.84%) | (43.20%) | (15.03%) |
| Net margin | (1,193.87%) | (36.80%) | (20.40%) |
| Free cash flow margin | (866.56%) | (21.29%) | (7.24%) |
| Return on equity | 364.89% | (17.35%) | (15.32%) |
| Return on assets | (167.51%) | (14.19%) | (19.72%) |
| Return on invested capital | (3,096.53%) | (63.16%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack